Dr. George Mills of the FDA Joins CBI Advisory Board - August 2005

31 August 2005 – CBI is pleased to announce that George Mills, M.D., Director of the Division of Medical Imaging and Radiopharmaceutical Drug Products at the U.S. Food and Drug Administration, has agreed to join CBI’s advisory board.

CBI also notes the departure of Jerry Collins, PhD, from its advisory board, due to his transition as the Director of Pharmacology at Food and Drug Administration to become the Associate Director of the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.